Cocrystal Pharma (COCP) Metrics: History & Chart

Cocrystal Pharma, Inc.(COCP)

Biotechnology · Bothell, WA

$1.12+0.01 (+0.77%)

Delayed quote: Oct 6, 2026, 12:08 PM EDT

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses. Its current pipeline includes CC-31244, a non-nucleoside polymerase inhibitor for HCV, which has successfully completed Phase IIa clinical trials. Additionally, CC-42344, a PB2 inhibitor designed to combat influenza, is currently undergoing preclinical development. Cocrystal Pharma is also actively pursuing the development of non-nucleoside polymerase inhibitors to address norovirus infections. The company maintains strategic alliances, including a research and licensing collaboration with Merck Sharp & Dohme Corp. for the discovery and development of proprietary influenza A/B antiviral agents. It also holds a licensing agreement with the Kansas State University Research Foundation, aimed at advancing antiviral compounds for norovirus and coronavirus infections. Furthermore, Cocrystal Pharma engages in drug discovery collaborations with both HitGen and InterX Inc. The company's operations are headquartered in Bothell, Washington.

Bothell, WA

10 employees

www.cocrystalpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: James E. Sapirstein

View full financials

Third-Party DCF Estimate (FMP)	$0.47
Price Gap vs Third-Party Estimate	-57.27%

7D Total Return	-8.26%
30D Total Return	-1.77%
YTD Total Return	+13.38%
1Y Total Return	-8.26%
3Y Total Return	-45.59%
5Y Total Return	-90.46%
10Y Total Return	-99.37%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+13.38%
2025	-51.53%
2024	+17.44%
2023	-11.80%
2022	-75.00%
2021	-52.21%
2020

CAGR TTM	-8.23%
CAGR 3Y	-18.36%
CAGR 5Y	-37.50%
CAGR 10Y	-39.76%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	70.21
PE Ratio Avg TTM	197.01
PE Ratio Avg 3Y	197.01
Current VS TTM Avg	-64.36%
Current VS 3Y Avg	-64.36%
Current VS 5Y Avg	-61.97%

All Metrics

COCP Valuation Metrics

COCP Stock Price Metrics

COCP Dividend Metrics

COCP Growth Rate Metrics

COCP Discounted Cash Flow Metrics

COCP Returns By Period

COCP Yearly Returns

COCP Average Annual Returns By Period (CAGR)

COCP Revenue Metrics

COCP PE Ratio Metrics

COCP PS Ratio Metrics

COCP PB Ratio Metrics

COCP Price to Free Cash Flow Ratio Metrics

COCP Debt to Equity Ratio Metrics

COCP PEG Ratio Metrics

COCP FCF Yield

COCP Earnings Yield

COCP EBITDA Yield

COCP OCF Yield

COCP EV/EBIT Ratio Metrics

COCP EV/EBITDA Ratio Metrics

COCP EV/Assets Ratio Metrics

COCP EV/Sales Ratio Metrics

COCP Current Ratio Metrics

COCP Quick Ratio Metrics

COCP ROIC Metrics

COCP Return on Assets Metrics

COCP Return on Equity Metrics

COCP Net Profit Margin Metrics

COCP Gross Profit Margin Metrics

COCP Tax Rate Metrics

PS Ratio	46.38
PS Ratio Avg TTM	57.02
PS Ratio Avg 3Y	57.02
Current VS TTM Avg	-18.66%
Current VS 3Y Avg	-18.66%
Current VS 5Y Avg	-46.07%

PB Ratio	14.66
PB Ratio Avg TTM	2.25
PB Ratio Avg 3Y	1.57
Current VS TTM Avg	+550.14%
Current VS 3Y Avg	+831.40%
Current VS 5Y Avg	+1269.75%

PFCF Ratio	78.28
PFCF Ratio Avg TTM	83.07
PFCF Ratio Avg 3Y	83.07
Current VS TTM Avg	-5.77%
Current VS 3Y Avg	-5.77%
Current VS 5Y Avg	-5.77%

Debt/Equity Ratio	1.28
Debt/Equity Ratio Avg TTM	0.48
Debt/Equity Ratio Avg 3Y	0.16
Current VS TTM Avg	+169.23%
Current VS 3Y Avg	+695.47%
Current VS 5Y Avg	+1187.71%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.28%
FCF Yield Avg TTM	1.21%
FCF Yield Avg 3Y	1.21%
Current VS TTM Avg	+6.00%
Current VS 3Y Avg	+6.00%
Current VS 5Y Avg	+6.00%

Earnings Yield	1.42%
Earnings Yield Avg TTM	0.79%
Earnings Yield Avg 3Y	0.79%
Current VS TTM Avg	+80.37%
Current VS 3Y Avg	+80.37%
Current VS 5Y Avg	+73.10%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	3.11
Ev/Assets Ratio Avg TTM	0.91
Ev/Assets Ratio Avg 3Y	0.70
Current VS TTM Avg	+242.35%
Current VS 3Y Avg	+342.88%
Current VS 5Y Avg	+382.96%

Ev/Sales Ratio	43.87
Ev/Sales Ratio Avg TTM	46.98
Ev/Sales Ratio Avg 3Y	46.98
Current VS TTM Avg	-6.62%
Current VS 3Y Avg	-6.62%
Current VS 5Y Avg	+21.34%

Current Ratio	1.24
Current Ratio Avg TTM	3.41
Current Ratio Avg 3Y	6.42
Current VS TTM Avg	-63.73%
Current VS 3Y Avg	-80.74%
Current VS 5Y Avg	-92.44%

Quick Ratio	1.24
Quick Ratio Avg TTM	3.41
Quick Ratio Avg 3Y	6.42
Current VS TTM Avg	-63.73%
Current VS 3Y Avg	-80.74%
Current VS 5Y Avg	-92.44%

ROIC	(497.29%)
ROIC Avg 3Y	(118.25%)
ROIC Avg 5Y	(92.90%)
Current VS 3Y Avg	-320.54%
Current VS 5Y Avg	-435.30%
Current VS 10Y Avg	-518.84%

ROA	(213.77%)
ROA Avg TTM	(33.55%)
ROA Avg 3Y	(21.18%)
Current VS TTM Avg	-537.08%
Current VS 3Y Avg	-909.12%
Current VS 5Y Avg	-1206.86%

ROE	(951.92%)
ROE Avg TTM	(333.51%)
ROE Avg 3Y	(135.35%)
Current VS TTM Avg	-185.43%
Current VS 3Y Avg	-603.31%
Current VS 5Y Avg	-822.30%

Net Profit Margin	(3011.52%)
Net Profit Margin Avg TTM	(807.02%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	-273.16%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	31.91%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.20%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	0.10%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+100.00%
Current VS 10Y Avg	+247.22%